<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Hepatol</journal-id>
      <journal-id journal-id-type="publisher-id">KJHEP</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Hepatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1738-222X</issn>
      <issn pub-type="epub">2093-8047</issn>
      <publisher>
        <publisher-name>The Korean Association for the Study of the Liver</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22310796</article-id>
      <article-id pub-id-type="pmc">3304659</article-id>
      <article-id pub-id-type="doi">10.3350/kjhep.2011.17.4.313</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Joo Ho</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Yung Sang</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Pyo Nyun</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Beom Hee</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Gu-Whan</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoo</surname>
            <given-names>Han-Wook</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Heo</surname>
            <given-names>Nae-Yun</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lim</surname>
            <given-names>Young-Suk</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Han Chu</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Young-Hwa</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Suh</surname>
            <given-names>Dong Jin</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Internal Medicine, Vievis Namuh Hospital, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</aff>
      <aff id="A4"><label>4</label>Medical Genetics Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</aff>
      <aff id="A5"><label>5</label>Department of Internal Medicine, Inje University Haeundae Paik-Hospital, Inje University College of Medicine, Busan, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Yung Sang Lee. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. Tel. +82-2-3010-3190, Fax. +82-2-485-5782, <email>yungslee@amc.seoul.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>12</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <issue>4</issue>
      <fpage>313</fpage>
      <lpage>318</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>4</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>15</day>
          <month>6</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>6</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2011 by The Korean Association for the Study of the Liver</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>This is a case report of a 68-year-old man with hepatocellular carcinoma (HCC) accompanied by hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, and hepatic vascular malformation. HHT is an autosomal dominant disorder of the fibrovascular tissue that is characterized by recurrent epistaxis, mucocutaneous telangiectasias, and visceral arteriovenous malformations. HHT is caused by mutation of the genes involved in the signaling pathway of transforming growth factor-&#x3B2;, which plays an important role in the formation of vascular endothelia. Hepatic involvement has been reported as occurring in 30-73% of patients with HHT. However, symptomatic liver involvement is quite rare, and the representative clinical presentations of HHT in hepatic involvement are high-output heart failure, portal hypertension, nodular regenerative hyperplasia, and symptoms of biliary ischemia. Some cases of HCC in association with HHT have been reported, but are very rare. We present herein the characteristic radiologic and genetic findings of HHT that was diagnosed during the evaluation and treatment of HCC.</p>
      </abstract>
      <kwd-group>
        <kwd>Osler-Weber-Rendu disease</kwd>
        <kwd>Hereditary hemorrhagic telangiectasia</kwd>
        <kwd>Hepatic arteriovenous malformation</kwd>
        <kwd>Hepatocellular carcinoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is an autosomal dominant multiorgan disorder caused by a genetic defect encoding a protein that binds transforming growth factor, which results in abnormal vascular remodeling in the form of fibrovascular dysplasia with multiple telangiectasias.<xref ref-type="bibr" rid="B1">1</xref> HHT is caused by mutations in one of two genes that have led to its subclassification into type 1 or 2 disease in most cases. HHT type 1 disease, the disease-causing gene is located on chromosome 9, encoding endoglin (<italic>ENG</italic>).<xref ref-type="bibr" rid="B2">2</xref> In HHT type 2, the disease-causing gene is located on chromosome 12, encoding activin receptor-like kinase 1 (<italic>ACVRL1</italic>).<xref ref-type="bibr" rid="B3">3</xref> HHT is characterized by the classic triad of mucocutaneous telangiectasias, recurrent epistaxis, and familial occurrence.<xref ref-type="bibr" rid="B4">4</xref> Multiple telangiectases consisting of thin-walled, dilated vascular channels with arteriovenous malformations may involve mucocutaneous tissue, gastrointestinal tract including the liver, lung, and brain.<xref ref-type="bibr" rid="B5">5</xref> The condition usually manifests in adults with epistaxis, hemoptysis, or both, and hepatic involvement is typically diagnosed 10-20 years after the first telangiectasias appear.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref> The diagnosis of HHT is established when any three of the following criteria are present: (1) spontaneous and recurrent epistaxis; (2) multiple telangiectasias at characteristic sites, including lips, oral cavity, fingers, and nose; (3) presence of internal lesions such as gastrointestinal telangiectasia, pulmonary, hepatic, cerebral, and spinal arteriovenous malformations (AVMs); and (4) family history in the first-digree relative.<xref ref-type="bibr" rid="B8">8</xref></p>
      <p>Although the genotypic-phenotypic correlations are not yet fully defined, disease severity is more pronounced in HHT type 1 than in HHT type 2 with earlier age of onset for epistaxis and hepatic involvement were observed predominantly in HHT type 2.<xref ref-type="bibr" rid="B9">9</xref> We present here a case of HHT type 2 with hepatic involvement with hepatocellular carcinoma (HCC) and confirmed by the mutation in the <italic>ACVRL1</italic>. Transarterial chemoembolization (TACE) for the unresectable HCC was not effective in this case and even risky procedure when HCC is associated with HHT.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 68-year-old man was referred for evaluation of a hepatic mass. He had history of hepatitis B virus carrier for 20 years and liver cirrhosis for 3 years. He has been taking an angiotensin receptor blocker and digoxin due to hypertension and heart failure. He has suffered from repeated episodes of epistaxis from his teens and gastrointestinal bleeding from his mid-thirties. All of his five children also had the history of recurrent epistaxis. Also his sister was suffering from the sequelae of cerebrovascular accident. On physical examination, several telangiectatic macular lesions were found on his arms and trunk (<xref ref-type="fig" rid="F1">Fig. 1A, 1B</xref>). The laboratory work-up at first visit revealed the following: WBC, 4.6&#xD7;10<sup>3</sup>/mm<sup>3</sup>; platelet, 172&#xD7;10<sup>3</sup>/mm<sup>3</sup>; hemoglobin, 12.6 g/dL; aspartate aminotransferase (AST), 42 IU/L; alanine aminotranferase (ALT), 20 IU/L; hepatitis B virus surface antigen, positive; hepatitis B surface antibody, negative; anti-hepatitis C virus antibody, negative; and alpha-fetoprotein (AFP), 345 ng/mL (normal, 0-20). Other laboratory results including bleeding time, coagulation time, prothrombin time and activated partial thromboplastin time were normal. Gastroduodenal endoscopy disclosed a telangiectasia at the lesser curvature in mid-body of the stomach (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). Liver dynamic CT (LDCT) revealed multiple HCCs in the right lobe of liver and there was no evidence of distant metastasis or vascular invasion. The HCC lesions showed heterogenous wash-out compared to well enhancing round homogenous AVMs in delayed phase of LDCT (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
      <p>Liver transplantation was recommended, however, the patient refused it due to economic problem. TACE was performed in three consecutive sessions, but lipiodol uptake in the tumor mass was very poor at every session. HCC progressed after each TACE session. Fever developed up to 38&#x2103;, and AST and/or ALT increased more than two times of baseline following the first two TACE sessions.</p>
      <p>Because of unusual TACE effect, we reviewed all the radiologic images of the patient and found an enlarged tortuous hepatic artery, multiple arteriovenous malformations, and early visualization of hepatic veins in LDCT (<xref ref-type="fig" rid="F2">Fig. 2</xref>) and hepatic angiography (<xref ref-type="fig" rid="F3">Fig. 3</xref>). Based on these findings and positive family history, he was diagnosed as Osler-Weber-Rendu disease and genetic tests for the <italic>ENG</italic> and <italic>ACVRL1</italic> were performed. Patient's genomic DNA was isolated from peripheral blood using the QuickGene DNA blood kit (Fujifilm, Tokyo, Japan) and BigDye Terminatore V3.1 Cycle Sequencing Ready reaction kit (Applied Biosystems, Foster city, CA, USA). Fourteen and ten exons and their intronic flanking sequences of the <italic>ENG</italic> and <italic>ACVRL1</italic>, respectively, were amplified by polymerase chain reaction with appropriate primers (<xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F4">Fig. 4</xref>). The molecular genetic analysis for the whole exons with their flanking sequences of the <italic>ENG</italic> was negative. However, the patient harbors a deletion mutation, c.145del (p.Ala49ProfsX5), in the <italic>ACVRL</italic>, the diagnosis of HHT type 2 with hepatic involvement was confirmed by the results of genetic study. He is waiting for deceased donor liver transplantation for the treatment of HCC.</p>
    </sec>
    <sec>
      <title>DISCUSSION</title>
      <p>HHT or Osler-Weber-Rendu disease is a rare systemic fibrovascular dysplasia with autosomal dominant transmission, characterized by recurrent epistaxsis, mucocutaneous telangiectasis, and visceral AVMs.<xref ref-type="bibr" rid="B1">1</xref> It has an estimated prevalence of 1 in 5,000-10,000. Recurrent epistaxis is often the first and most common manifestation.<xref ref-type="bibr" rid="B4">4</xref> The dilated post capillary venule fuses with an arteriole bypassing the capillary system and resulting in an arterio-venous communication.<xref ref-type="bibr" rid="B5">5</xref></p>
      <p>HHT is caused by the mutation of the genes involved in the transforming growth factor-&#x3B2; signaling pathway which plays an important role in the formation of vascular endothelium.<xref ref-type="bibr" rid="B8">8</xref> Two major types of HHT (HHT type 1 and type 2) are due to mutations of <italic>ENG</italic> and <italic>ACVRL</italic>, respectively. The <italic>ENG</italic> is located on the long arm of chromosome 9 (9q33-34) and determine the HHT type 1 disease, which correlates with a more critical pulmonary involvement and earlier age of onset for epistaxis.<xref ref-type="bibr" rid="B10">10</xref> The <italic>ACVRL1</italic> located on the long arm of chromosome 12 (12q13) indicate the HHT type 2 disease, with a predominance of liver involvement.<xref ref-type="bibr" rid="B2">2</xref> Although the genotypic-phenotypic correlations are not yet fully defined, it appears that the liver involvement is more prevalent in HHT type 2. Our case also revealed to have the deletion mutation in the <italic>ACVRL</italic>, and the diagnosis of HHT type 2 was made. He showed epistaxsis, mucocutaneous telangiectasis and predominant hepatic AVMs with family history.</p>
      <p>Hepatic involvement occurs in 30% to 73% of patients with HHT.<xref ref-type="bibr" rid="B11">11</xref> However, most of them are asymptomatic. Symptomatic liver involvement is quite rare and symptoms occur in about 8% of the patients with HHT and liver vascular malformations.<xref ref-type="bibr" rid="B3">3</xref> Patients with hepatic involvement have hyperdynamic circulation resulting from arteriovenous shunting, portovenous shunting, or both, and may develop high-output cardiac failure. Other complications include extrahepatic shunts, portal hypertension, hepatic portosystemic encephalopathy, biliary ischemia, cholangitis, and liver failure.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref> The development of portal hypertension is mostly the result of shunting of blood from the hepatic artery to the portal vein. Perfusion abnormalities and tissue ischemia in the liver parenchyma can induce fibrosis around the abnormal vessels and hepatocellular regenerative activity. The combination of fibrotic telangiectases and nodular regenerative hyperplasia makes it hard to diagnose true hepatic mass lesions.<xref ref-type="bibr" rid="B11">11</xref></p>
      <p>The LDCT can demonstrate an enlarged hepatic artery, arteriovenous shunt, and early draining hepatic vein in the liver.<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref> Hepatic arteriography can be the best method of screening to characterize the liver vascular malformations.</p>
      <p>The diagnosis of HCC is not easy in the background of the liver involved by HHT, because typical arterial enhancement and delayed washout pattern of HCC in dynamic CT scan could be masked by widespread AVMs and focal nodular hyperplasia common in HHT.<xref ref-type="bibr" rid="B10">10</xref> In our case, the diagnosis of HCC was possible due to typical radiologic features and elevated AFP level without liver biopsy.</p>
      <p>HCC associated with HHT were rarely reported. Two cases reports have been published since 1975.<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref> It has been suggested that development of HCC in HHT patients might be due to increased liver cell turnover resulted from 'over-nourishment' of liver sinusoids by hepatic AVMs. So far, the causal relationship between HHT and HCC development is not clear.</p>
      <p>TACE is one of effective treatment modalities especially in patients with unresectable HCC.<xref ref-type="bibr" rid="B16">16</xref> However, the presence of AVMs due to HHT could be an important barrier of effective TACE because blockade at feeding vessel in tumor is frequently impossible due to presence of AVMs. Usually the intrahepatic biliary tree obtains nearly all of its blood from the hepatic artery, so the presence of natural shunt from the hepatic artery to the hepatic or portal vein will result in biliary ischemia.<xref ref-type="bibr" rid="B17">17</xref> In this situation, the hepatic artery embolization might be a quite risky procedure.<xref ref-type="bibr" rid="B3">3</xref> In this case, three sessions of TACE were performed for the treatment of HCC, but those were ineffective and more severe deterioration of liver function was observed after TACE.</p>
      <p>No treatment is recommended for HHT patients with asymptomatic liver involvement. In HHT patients with symptomatic liver disease, treatment can be divided into symptomatic treatment for the specific complications and management aimed at reducing the shunt by surgical ligation or transarterial embolization.<xref ref-type="bibr" rid="B3">3</xref> However, the hepatic artery embolization/ligation should be considered mainly in non-transplant candidate who failed maximal medical therapy due to the risk of necrotizing cholangitis and liver failure. Orthotopic liver transplantation has been proposed as the only definitive curative option for the symptomatic liver involvement in HHT.<xref ref-type="bibr" rid="B18">18</xref></p>
      <p>In conclusion, the diagnosis of HCC in the liver involved by HHT can be difficult due to its vascular malformation and regenerative nodular hyperplasia. TACE is ineffective in patients with HCC associated with HHT, therefore liver transplantation should be considered as the first-line treatment modality. We report here a case of HHT, presenting with HCC which developed in the background of multiple intrahepatic AVMs.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ACVRL1</term>
          <def>
            <p>activin receptor-like kinase 1</p>
          </def>
        </def-item>
        <def-item>
          <term>AFP</term>
          <def>
            <p>alpha-fetoprotein</p>
          </def>
        </def-item>
        <def-item>
          <term>ALT</term>
          <def>
            <p>alanine aminotranferase</p>
          </def>
        </def-item>
        <def-item>
          <term>AST</term>
          <def>
            <p>aspartate aminotransferase</p>
          </def>
        </def-item>
        <def-item>
          <term>AVM</term>
          <def>
            <p>arteriovenous malformations</p>
          </def>
        </def-item>
        <def-item>
          <term>CT</term>
          <def>
            <p>computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>ENG</term>
          <def>
            <p>endoglin</p>
          </def>
        </def-item>
        <def-item>
          <term>HBsAg</term>
          <def>
            <p>hepatitis B virus surface antigen</p>
          </def>
        </def-item>
        <def-item>
          <term>HCC</term>
          <def>
            <p>hepatocellular carcinoma</p>
          </def>
        </def-item>
        <def-item>
          <term>HHT</term>
          <def>
            <p>hereditary hemorrhagic telangiectasia</p>
          </def>
        </def-item>
        <def-item>
          <term>LDCT</term>
          <def>
            <p>liver dynamic CT</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>TACE</term>
          <def>
            <p>transarterial chemoembolization</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Begbie</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Shovlin</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century</article-title>
          <source>Postgrad Med J</source>
          <year>2003</year>
          <volume>79</volume>
          <fpage>18</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">12566546</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bossler</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Godmilow</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ganguly</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype</article-title>
          <source>Hum Mutat</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>667</fpage>
          <lpage>675</lpage>
          <pub-id pub-id-type="pmid">16752392</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Tsao</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Liver involvement in hereditary hemorrhagic telangiectasia (HHT)</article-title>
          <source>J Hepatol</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>499</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">17239481</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sadick</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sadick</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>G&#xF6;tte</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Naim</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Riedel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bran</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures</article-title>
          <source>Wien Klin Wochenschr</source>
          <year>2006</year>
          <volume>118</volume>
          <fpage>72</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">16703249</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haitjema</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Westermann</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Overtoom</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Timmer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Disch</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mauser</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment</article-title>
          <source>Arch Intern Med</source>
          <year>1996</year>
          <volume>156</volume>
          <fpage>714</fpage>
          <lpage>719</lpage>
          <pub-id pub-id-type="pmid">8615703</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buscarini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Plauchu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Garcia Tsao</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>RI</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Sabb&#xE0;</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations</article-title>
          <source>Liver Int</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>1040</fpage>
          <lpage>1046</lpage>
          <pub-id pub-id-type="pmid">17032403</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larson</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Liver disease in hereditary hemorrhagic telangiectasia</article-title>
          <source>J Clin Gastroenterol</source>
          <year>2003</year>
          <volume>36</volume>
          <fpage>149</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">12544200</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shovlin</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Guttmacher</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Buscarini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Faughnan</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Hyland</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Westermann</surname>
              <given-names>CJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)</article-title>
          <source>Am J Med Genet</source>
          <year>2000</year>
          <volume>91</volume>
          <fpage>66</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">10751092</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Letteboer</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Mager</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Snijder</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Koeleman</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Lindhout</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ploos van Amstel</surname>
              <given-names>JK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia</article-title>
          <source>J Med Genet</source>
          <year>2006</year>
          <volume>43</volume>
          <fpage>371</fpage>
          <lpage>377</lpage>
          <pub-id pub-id-type="pmid">16155196</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carette</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Nedelcu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tassart</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grange</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Wislez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Khalil</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Imaging of hereditary hemorrhagic telangiectasia</article-title>
          <source>Cardiovasc Intervent Radiol</source>
          <year>2009</year>
          <volume>32</volume>
          <fpage>745</fpage>
          <lpage>757</lpage>
          <pub-id pub-id-type="pmid">18972161</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buscarini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Danesino</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Olivieri</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lupinacci</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zambelli</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease</article-title>
          <source>Dig Liver Dis</source>
          <year>2005</year>
          <volume>37</volume>
          <fpage>635</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="pmid">15923156</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ianora</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Memeo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sabba</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cirulli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rotondo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Angelelli</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement</article-title>
          <source>Radiology</source>
          <year>2004</year>
          <volume>230</volume>
          <fpage>250</fpage>
          <lpage>259</lpage>
          <pub-id pub-id-type="pmid">14645886</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buscarini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Buscarini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Civardi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Arruzzoli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bossalini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Piantanida</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>1994</year>
          <volume>163</volume>
          <fpage>1105</fpage>
          <lpage>1110</lpage>
          <pub-id pub-id-type="pmid">7976883</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sussman</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Sternberg</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Hereditary hemorrhagic telangiectasia. A case with hepatocellular carcinoma and acquired hepatocerebral degeneration</article-title>
          <source>Arch Pathol</source>
          <year>1975</year>
          <volume>99</volume>
          <fpage>95</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">163631</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jameson</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Primary hepatocellular carcinoma in hereditary haemorrhagic telangiectasia: a case report and literature review</article-title>
          <source>Histopathology</source>
          <year>1989</year>
          <volume>15</volume>
          <fpage>550</fpage>
          <lpage>552</lpage>
          <pub-id pub-id-type="pmid">2557276</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Llovet</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Real</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Monta&#xF1;a</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Planas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Coll</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aponte</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial</article-title>
          <source>Lancet</source>
          <year>2002</year>
          <volume>359</volume>
          <fpage>1734</fpage>
          <lpage>1739</lpage>
          <pub-id pub-id-type="pmid">12049862</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blewitt</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Wyatt</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia</article-title>
          <source>Histopathology</source>
          <year>2003</year>
          <volume>42</volume>
          <fpage>265</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">12605646</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scelzo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Greco</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bonanni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Di Cocco</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>D'Angelo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Laurenzi</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of liver transplantation in the treatment of hereditary hemorrhagic telangiectasia: a short literature review</article-title>
          <source>Transplant Proc</source>
          <year>2007</year>
          <volume>39</volume>
          <fpage>2045</fpage>
          <lpage>2047</lpage>
          <pub-id pub-id-type="pmid">17692689</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Typical splinter-like telangiectasias on the patient's arm (A), trunk (B), and midbody of the stomach (C).</p>
      </caption>
      <graphic xlink:href="kjhep-17-313-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Dynamic liver CT images of hereditary hemorrhagic telangiectasia (HHT) and hepatocellular carcinoma (HCC) in a 68-year-old man. (A) In the arterial phase, the CT angiogram showed diffuse parenchymal heterogeneous enhancement and numerous telangiectasias, mainly in hepatic segment IV (arrow), which is characteristic of HHT. (B) Delayed washout of HCC (arrow) was observed in hepatic segment VII. (C) Post-transarterial chemoembolization (TACE) CT image obtained in the arterial phase showing early filling of the mid-hepatic vein (thin arrow) with a hepatic artery to hepatic vein shunt (thick arrow). (D) The same CT image as in <xref ref-type="fig" rid="F2">Fig. 2C</xref> showing left hepatic artery enlargement (thick arrow) and multiple vascular malformations (thin arrows).</p>
      </caption>
      <graphic xlink:href="kjhep-17-313-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Hepatic arteriogram obtained during TACE. (A) Early hepatic arteriogram showing diffuse parenchymal heterogeneity with a mosaic pattern of perfusion characterized by multiple irregular telangiectatic vascular lesions (arrows). (B) Late hepatic arteriogram showing a dilated, tortuous hepatic artery (thick arrow) and early filling of the hepatic vein (thin arrow).</p>
      </caption>
      <graphic xlink:href="kjhep-17-313-g003"/>
    </fig>
    <fig id="F4" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Molecular genetic analysis for the entire exons with their flanking sequences was negative for <italic>ENG</italic>. However, the patient harbored a deletion mutation, c.145del (p.Ala49ProfsX5), in <italic>ACVRL1</italic> (arrow).</p>
      </caption>
      <graphic xlink:href="kjhep-17-313-g004"/>
    </fig>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Sequences of primers used in the polymerase chain reaction</p>
      </caption>
      <graphic xlink:href="kjhep-17-313-i001"/>
      <table-wrap-foot>
        <fn>
          <p>ACVRL1, activin receptor-like kinase 1; ENG, endoglin.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
